Streptavidin-biotin binding process

Streptavidin is a protein that is used extensively in molecular biology applications. Due to its exceptionally high affinity to biotin, it is among the strongest non-covalent interactions in nature. The small size of biotin makes it a popular choice for protein and cell labeling. Dynabeads streptavidin magnetic beads utilize this strong interaction to isolate cell populations, isolate target proteins, capture nucleic acids, synthesize mRNA, and prepare samples for next-generation sequencing (NGS) workflows. Learn more about the applications of using Dynabeads streptavidin beads.

Explore the page:

Dynabeads streptavidin bead selection table

Table 1. Streptavidin beads by target and application


Streptavidin beads for target sequence enrichment

NGS as a high-throughput, massive parallel sequencing technology enables the sequencing of DNA and RNA for studying genetic variations associated with diseases and other biological processes. Applications include whole genome sequencing, deep sequence of target regions, and identification of new pathogens to further advance infectious disease and microbial research.

The four key steps for NGS workflow generally include library preparation, clonal amplification, library sequencing, and data analysis. Dynabeads Streptavidin for Target Enrichment is excellent for the enrichment of biotinylated target nucleic acid sequences made during the library prep as part of the NGS workflow (Figure 1).

Figure 1. The NGS workflow. The first step for NGS is library preparation, followed by hybridization, target enrichment, PCR, and sequencing. Dynabeads Streptavidin for Target Enrichment is intended for the enrichment of the target sequences hybridized on the biotinylated probe that is immobilized to the streptavidin-coated magnetic beads (shown in red). The hybridization step can either be performed prior to the bead-based target enrichment step (indirect hybrid capture technique) or after the biotinylated probe is bound to the streptavidin beads (direct hybrid capture technique).

Bead-based target enrichment for NGS

Target enrichment by hybridization allows capture and therefore sufficient coverage of genomic regions from degraded sample types whether using DNA, RNA, or circulating cell-free DNA from blood. The biotinylated probes (also known as bait) immobilize the oligonucleotides onto the bead surface by binding with 1 μm in diameter streptavidin beads (Figure 2). The isolated and purified target regions are subsequently amplified and prepared for sequencing.

Dynabeads Streptavidin for Target Enrichment provides the following advantages:

  • High purity—helps minimize non-specific binding
  • High reproducibility—helps achieve consistent results and can help reduce the risk of failure
  • High sensitivity—secures successful NGS workflow
  • Automation—enables high-throughput enrichment
Diagrammed steps of nucleic acid extraction using Dynabeads streptavidin

Figure 2. Hybridization capture with streptavidin beads. Streptavidin beads immobilize the biotinylated ligand and use it as bait to capture target nucleic acid sequences.

Performance of Dynabeads Streptavidin for Target Enrichment in a sequencing workflow vs comparable products

Figure 3. Streptavidin magnetic beads comparison: mean concentration of final libraries. We measured concentrations (nM) of final libraries for Dynabeads Streptavidin for Target Enrichment (red bar), a positive control (gray bar), and streptavidin magnetic beads from four other vendors. The concentration of final libraries was calculated based on the concentration of the library fragments and the size distribution. For downstream exome sequencing, the acceptance criteria was set to 2.5 nM. n=3.

Figure 4. Streptavidin magnetic beads comparison: mean coverage. Mean sequencing coverage for Dynabeads Streptavidin for Target Enrichment (red bar), a positive control (gray bar), and streptavidin magnetic beads from the two vendors that passed the target enrichment concentration criteria outlined in Figure 3. The mean coverage is expressed as an average of the triplicates, all samples were prepared in triplicates (n=3). The error bar is the standard deviation. Dynabeads Streptavidin for Target Enrichment gave the deepest coverage (most reads from which to build a consensus and the greatest accuracy).

Figure 5. Streptavidin magnetic beads comparison: average depth of coverage. The % of reference sequence covered vs the coverage depth for Dynabeads Streptavidin for Target Enrichment (red bars), a positive control (gray bars), and streptavidin magnetic beads from the two vendors that passed the target enrichment concentration criteria outlined in Figure 3. For Dynabeads Streptavidin for Target Enrichment at 60x, 97.53% of the reference is covered with a minimum of 60 reads. This performance of the Dynabeads Streptavidin for Target Enrichment is particularly important for clinical applications and identification of rare variants where deep coverage (e.g., 60x) is essential.


Streptavidin beads for mRNA synthesis

Streptavidin beads can be used for mRNA synthesis by in vitro transcription (IVT), an application/workflow that can greatly accelerate the research and development of mRNA vaccines. The mRNA is synthesized using a biotinylated DNA template of choice, amplified via PCR, and immobilized to streptavidin beads (Figure 6). The immobilized template can be reused in the next IVT reaction at least six times.

Figure 6. mRNA synthesis workflow with Dynabeads Streptavidin for In Vitro Transcription. This workflow begins with the biotinylated PCR product. This mRNA template is then immobilized to the Dynabeads Streptavidin for In Vitro Transcription beads forming a bead-template complex. Using this complex, IVT can be performed up to six consecutive times. The target mRNA is then ready to be eluted from the streptavidin beads via magnetic separation and incubation with elution buffer.

mRNA synthesis by in vitro transcription (IVT)

mRNA synthesis by IVT begins with the biotinylated template, which is made by PCR amplification of the target sequence in a plasmid construct or in a synthetic DNA construct using a biotinylated forward primer located 30–100 bps upstream of the T7-promoter and a non-biotinylated reverse primer (Figure 7). The biotinylated template is immobilized to the streptavidin beads without the need for prior purification. The streptavidin bead-bound template is used directly in IVT, then removed from the synthesized mRNA by magnetic separation. The isolated and purified target regions are subsequently amplified and prepared for sequencing.

Dynabeads Streptavidin for In Vitro Transcription is designed for simple and scalable mRNA synthesis. Product benefits include:

  • Reusability—reuse the DNA template at least six times to minimize plasmid preparation and reduce hands-on time
  • Flexibility—choose synthetic or plasmid DNA template for mRNA IVT for greater flexibility of mRNA design
  • Automation— enables high-throughput synthesis and purification of many samples simultaneously


Streptavidin beads for protein and cell capture

When used in combination with a biotinylated probe/ligand, any target molecule can be captured on the Dynabeads streptavidin magnetic beads, isolated and then further manipulated. Depending on your target molecule and downstream assay, a variety of products are available for protein and cell capture using streptavidin magnetic beads. View Table 2 below to determine which product meets your specific research needs.
 

Table 2. Streptavidin magnetic beads for direct and indirect isolation

Recommended productsDynabeads M-280 StreptavidinDynabeads MyOne Streptavidin T1Dynabeads Biotin BinderCELLection Biotin Binder KitDynabeads FlowComp Flexi Kit
Description
  • Hydrophobic bead surface
  • Based on tosylactivated beads
  • Diameter: 2.8 µm
  • Size distribution:
    CV < 3%
  • BSA as blocking protein
  • Isoelectric point: pH 5.0
  • Low charge (–10 mV (at pH 7)
  • Iron content (Ferrites): 12% (17%)
  • Hydrophobic bead surface
  • Based on tosylactivated beads
  • Diameter: 1.05 µm
  • Size distribution: CV <3%
  • BSA as blocking protein
  • Isoelectric point: pH 5.0
  • Low charge (–10 mV (at pH 7)
  • Iron content (Ferrites): 26% (37%)
  • Low sedimentation rate and improved reaction kinetics compared to M-280/M-270 beads
  • For use with your own standard biotinylated antibodies
  • Isolate cells from whole blood, buffy coat, PBMC, MNC, or tissue digests
  • For use with your own standard biotinylated antibodies
  • Streptavidin on the bead-surface is attached via a DNA linker, providing a cleavable site to release and remove the beads after isolation
  • For use with your own standard biotinylated antibodies
  • DSB-X biotinylation of the antibody is required to assure release of the target cells from the bead
Capacity
  • Free biotin:
    490–750
    pmol/mg beads
  • Biotinylated
    Ig:
    5–10 µg/mg
    beads
  • Free biotin:
    950–1,500 pmol/mg beads
  • Biotinylated Ig:
    20 µg/mg beads
Processes 2 x 109 PBMCs or 200 mL whole bloodProcesses 2 x 109 PBMCs or 200 mL whole bloodProcesses 2 x 109 MNCs or 80 mL whole blood/buffy coat
Ideal applications
  • Immunoassays/
    Immunodiagnostics (for research use only)
  • Protein purification
  • Phage display
  • Biopanning
  • Cell isolation
  • Immunoassays/
    Immunodiagnostics (for research use only)
  • Protein purification
  • Phage display
  • Biopanning
  • Cell isolation
  • Automation
  • Depletion of one/multiple cell types from any sample from any species
  • Positive cell isolation for molecular downstream applications (without cell release)
  • Positive cell isolation and release
  • Isolate any cell from any sample from any species
  • Positive cell isolation and release
  • Isolate any cell from any sample from any species


Direct and indirect capture of molecules and cells with streptavidin beads

Depending on your target molecule and the specific application, the direct or indirect capture method can be applied using streptavidin magnetic beads (Figure 8).

For some applications, using a pre-coupled ligand in direct capture allows you to reuse the magnetic beads and thus further reduce sample preparation costs.

The indirect capture approach can be of benefit when the concentration of your target is low, the specific affinity is weak, or the binding kinetics is slow. In indirect capture, the probe/ligand is allowed to bind to the target in suspension prior to addition of the beads. A monolayer of streptavidin is covalently coupled to the magnetic beads, helping to reduce leakage that could otherwise disturb your assay.

Figure 8. Direct and indirect capture of molecules and cells with streptavidin magnetic beads. Direct capture uses a pre-coupled ligand that is added to the sample, incubated, then eluted via magnetic separation. Indirect capture begins with incubation of the biotinylated probe/ligand to the sample, then the streptavidin magnetic beads are added and incubated for some time, followed by elution off the magnetic bead by magnetic separation.

Order Dynabeads streptavidin beads for protein and cell capture now


Streptavidin beads for target sequence enrichment

NGS as a high-throughput, massive parallel sequencing technology enables the sequencing of DNA and RNA for studying genetic variations associated with diseases and other biological processes. Applications include whole genome sequencing, deep sequence of target regions, and identification of new pathogens to further advance infectious disease and microbial research.

The four key steps for NGS workflow generally include library preparation, clonal amplification, library sequencing, and data analysis. Dynabeads Streptavidin for Target Enrichment is excellent for the enrichment of biotinylated target nucleic acid sequences made during the library prep as part of the NGS workflow (Figure 1).

Figure 1. The NGS workflow. The first step for NGS is library preparation, followed by hybridization, target enrichment, PCR, and sequencing. Dynabeads Streptavidin for Target Enrichment is intended for the enrichment of the target sequences hybridized on the biotinylated probe that is immobilized to the streptavidin-coated magnetic beads (shown in red). The hybridization step can either be performed prior to the bead-based target enrichment step (indirect hybrid capture technique) or after the biotinylated probe is bound to the streptavidin beads (direct hybrid capture technique).

Bead-based target enrichment for NGS

Target enrichment by hybridization allows capture and therefore sufficient coverage of genomic regions from degraded sample types whether using DNA, RNA, or circulating cell-free DNA from blood. The biotinylated probes (also known as bait) immobilize the oligonucleotides onto the bead surface by binding with 1 μm in diameter streptavidin beads (Figure 2). The isolated and purified target regions are subsequently amplified and prepared for sequencing.

Dynabeads Streptavidin for Target Enrichment provides the following advantages:

  • High purity—helps minimize non-specific binding
  • High reproducibility—helps achieve consistent results and can help reduce the risk of failure
  • High sensitivity—secures successful NGS workflow
  • Automation—enables high-throughput enrichment
Diagrammed steps of nucleic acid extraction using Dynabeads streptavidin

Figure 2. Hybridization capture with streptavidin beads. Streptavidin beads immobilize the biotinylated ligand and use it as bait to capture target nucleic acid sequences.

Performance of Dynabeads Streptavidin for Target Enrichment in a sequencing workflow vs comparable products

Figure 3. Streptavidin magnetic beads comparison: mean concentration of final libraries. We measured concentrations (nM) of final libraries for Dynabeads Streptavidin for Target Enrichment (red bar), a positive control (gray bar), and streptavidin magnetic beads from four other vendors. The concentration of final libraries was calculated based on the concentration of the library fragments and the size distribution. For downstream exome sequencing, the acceptance criteria was set to 2.5 nM. n=3.

Figure 4. Streptavidin magnetic beads comparison: mean coverage. Mean sequencing coverage for Dynabeads Streptavidin for Target Enrichment (red bar), a positive control (gray bar), and streptavidin magnetic beads from the two vendors that passed the target enrichment concentration criteria outlined in Figure 3. The mean coverage is expressed as an average of the triplicates, all samples were prepared in triplicates (n=3). The error bar is the standard deviation. Dynabeads Streptavidin for Target Enrichment gave the deepest coverage (most reads from which to build a consensus and the greatest accuracy).

Figure 5. Streptavidin magnetic beads comparison: average depth of coverage. The % of reference sequence covered vs the coverage depth for Dynabeads Streptavidin for Target Enrichment (red bars), a positive control (gray bars), and streptavidin magnetic beads from the two vendors that passed the target enrichment concentration criteria outlined in Figure 3. For Dynabeads Streptavidin for Target Enrichment at 60x, 97.53% of the reference is covered with a minimum of 60 reads. This performance of the Dynabeads Streptavidin for Target Enrichment is particularly important for clinical applications and identification of rare variants where deep coverage (e.g., 60x) is essential.


Streptavidin beads for mRNA synthesis

Streptavidin beads can be used for mRNA synthesis by in vitro transcription (IVT), an application/workflow that can greatly accelerate the research and development of mRNA vaccines. The mRNA is synthesized using a biotinylated DNA template of choice, amplified via PCR, and immobilized to streptavidin beads (Figure 6). The immobilized template can be reused in the next IVT reaction at least six times.

Figure 6. mRNA synthesis workflow with Dynabeads Streptavidin for In Vitro Transcription. This workflow begins with the biotinylated PCR product. This mRNA template is then immobilized to the Dynabeads Streptavidin for In Vitro Transcription beads forming a bead-template complex. Using this complex, IVT can be performed up to six consecutive times. The target mRNA is then ready to be eluted from the streptavidin beads via magnetic separation and incubation with elution buffer.

mRNA synthesis by in vitro transcription (IVT)

mRNA synthesis by IVT begins with the biotinylated template, which is made by PCR amplification of the target sequence in a plasmid construct or in a synthetic DNA construct using a biotinylated forward primer located 30–100 bps upstream of the T7-promoter and a non-biotinylated reverse primer (Figure 7). The biotinylated template is immobilized to the streptavidin beads without the need for prior purification. The streptavidin bead-bound template is used directly in IVT, then removed from the synthesized mRNA by magnetic separation. The isolated and purified target regions are subsequently amplified and prepared for sequencing.

Dynabeads Streptavidin for In Vitro Transcription is designed for simple and scalable mRNA synthesis. Product benefits include:

  • Reusability—reuse the DNA template at least six times to minimize plasmid preparation and reduce hands-on time
  • Flexibility—choose synthetic or plasmid DNA template for mRNA IVT for greater flexibility of mRNA design
  • Automation— enables high-throughput synthesis and purification of many samples simultaneously


Streptavidin beads for protein and cell capture

When used in combination with a biotinylated probe/ligand, any target molecule can be captured on the Dynabeads streptavidin magnetic beads, isolated and then further manipulated. Depending on your target molecule and downstream assay, a variety of products are available for protein and cell capture using streptavidin magnetic beads. View Table 2 below to determine which product meets your specific research needs.
 

Table 2. Streptavidin magnetic beads for direct and indirect isolation

Recommended productsDynabeads M-280 StreptavidinDynabeads MyOne Streptavidin T1Dynabeads Biotin BinderCELLection Biotin Binder KitDynabeads FlowComp Flexi Kit
Description
  • Hydrophobic bead surface
  • Based on tosylactivated beads
  • Diameter: 2.8 µm
  • Size distribution:
    CV < 3%
  • BSA as blocking protein
  • Isoelectric point: pH 5.0
  • Low charge (–10 mV (at pH 7)
  • Iron content (Ferrites): 12% (17%)
  • Hydrophobic bead surface
  • Based on tosylactivated beads
  • Diameter: 1.05 µm
  • Size distribution: CV <3%
  • BSA as blocking protein
  • Isoelectric point: pH 5.0
  • Low charge (–10 mV (at pH 7)
  • Iron content (Ferrites): 26% (37%)
  • Low sedimentation rate and improved reaction kinetics compared to M-280/M-270 beads
  • For use with your own standard biotinylated antibodies
  • Isolate cells from whole blood, buffy coat, PBMC, MNC, or tissue digests
  • For use with your own standard biotinylated antibodies
  • Streptavidin on the bead-surface is attached via a DNA linker, providing a cleavable site to release and remove the beads after isolation
  • For use with your own standard biotinylated antibodies
  • DSB-X biotinylation of the antibody is required to assure release of the target cells from the bead
Capacity
  • Free biotin:
    490–750
    pmol/mg beads
  • Biotinylated
    Ig:
    5–10 µg/mg
    beads
  • Free biotin:
    950–1,500 pmol/mg beads
  • Biotinylated Ig:
    20 µg/mg beads
Processes 2 x 109 PBMCs or 200 mL whole bloodProcesses 2 x 109 PBMCs or 200 mL whole bloodProcesses 2 x 109 MNCs or 80 mL whole blood/buffy coat
Ideal applications
  • Immunoassays/
    Immunodiagnostics (for research use only)
  • Protein purification
  • Phage display
  • Biopanning
  • Cell isolation
  • Immunoassays/
    Immunodiagnostics (for research use only)
  • Protein purification
  • Phage display
  • Biopanning
  • Cell isolation
  • Automation
  • Depletion of one/multiple cell types from any sample from any species
  • Positive cell isolation for molecular downstream applications (without cell release)
  • Positive cell isolation and release
  • Isolate any cell from any sample from any species
  • Positive cell isolation and release
  • Isolate any cell from any sample from any species


Direct and indirect capture of molecules and cells with streptavidin beads

Depending on your target molecule and the specific application, the direct or indirect capture method can be applied using streptavidin magnetic beads (Figure 8).

For some applications, using a pre-coupled ligand in direct capture allows you to reuse the magnetic beads and thus further reduce sample preparation costs.

The indirect capture approach can be of benefit when the concentration of your target is low, the specific affinity is weak, or the binding kinetics is slow. In indirect capture, the probe/ligand is allowed to bind to the target in suspension prior to addition of the beads. A monolayer of streptavidin is covalently coupled to the magnetic beads, helping to reduce leakage that could otherwise disturb your assay.

Figure 8. Direct and indirect capture of molecules and cells with streptavidin magnetic beads. Direct capture uses a pre-coupled ligand that is added to the sample, incubated, then eluted via magnetic separation. Indirect capture begins with incubation of the biotinylated probe/ligand to the sample, then the streptavidin magnetic beads are added and incubated for some time, followed by elution off the magnetic bead by magnetic separation.

Order Dynabeads streptavidin beads for protein and cell capture now

Dynabeads streptavidin bead FAQs

Here are some frequently asked questions regarding the use of Dynabeads streptavidin magnetic beads.

How do you elute DNA from streptavidin beads?

A: Unless derivative forms of biotin or modified streptavidin have been adopted for your experiment, requiring a specific form and normally gentle way to dissociate biotin from streptavidin, often very harsh methods are required to dissociate the biotin from streptavidin which will denature the streptavidin. A couple of these methods are discussed below.

Biotinylated nucleic acids:
To dissociate biotinylated nucleic acids from streptavidin-coupled Dynabeads, incubate the beads in 95% formamide + 10 mM EDTA, pH 8.2 for 5 minutes at 65°C or for 2 minutes at 90°C. Pull the beads to the tube wall with the magnet and remove the supernatant containing the biotinylated nucleic acid from the tube.

Biotinylated proteins:
For biotinylated proteins, boil the beads in 0.1% SDS or SDS-PHAGE buffer for 3 min.

A: For most applications involving dissociation of biotinylated molecules from streptavidin, it is not possible to reuse the beads. The streptavidin-biotin bond is one of the strongest biological bonds known, and the conditions necessary to break this bond also destroy the streptavidin. However, if the Dynabeads streptavidin beads have been used in applications such as isolation of DNA binding proteins and release of proteins from DNA is done by gentle methods like using high-salt buffers that do not interfere with biotin-streptavidin interaction, the beads with the immobilized probe may be reused.

A: Use mild elution methods like buffers with high salt (>1 M NaOH) or low pH. Low pH elution buffers such as 0.1 M glycine•HCl, pH 2.5–3.0 are effective for most antibody-antigen interactions. Note that boiling in SDS will also elute the antibody.

Ordering information for streptavidin magnetic beads


Magnetic beads for PCR & NGS library prep size selection and cleanup

Need size selection and cleanup? Take your library prep to the next level with MagMAX Pure Bind Beads—cost-effective, energy-efficient, and high-performing magnetic beads.

Learn more


sho-streptavidin-dynabeads-230

모든 생체분자 졸화—
간단히 비오틴화된 리간드만 첨가

지난 15년 간 streptavidin-coupled Dynabeads®는 널리 사용되었고 여러 수동 및 자동 어플리케이션 대한 수천 건의 논문에 인용 되었습니다. Dynabeads®는 25,000가지 이상의 전세계 일반 IVD 장비에 사용됩니다. 출시된 streptavidin-coupled Dynabeads® 포트폴리오는 아래에 나와 있습니다.

Stylesheet for Classic Wide Template adjustments
Hero banner dark gradient overlay

Dynabeads® Streptavidin을 사용한 장점

  • 원심분리, 면역침전, 여과가 필요 없고, 자석만 있으면 됨
  • 확실하고 부드럽게 작용, 최적의 결합 반응속도 지원
  • 취급 단계가 거의 없고, 샘플 희석이 필요 없으며, 샘플 손실 최소화
  • 프로토콜을 쉽게 자동화

활용도를 높이기 위해 4가지 streptavidin-coupled Dynabeads®가 출시되어 있습니다. Dynabeads streptavidin 선택 가이드를 보면 다양한 특징을 확인할 수 있습니다.

또한, Dynabeads Streptavidin Trial Kit (각 비드 유형별로 1ml) 도 지원되므로, 자체 어플리케이션에서 직접 사용해 볼 수 있습니다.

Dynabeads® Streptavidin 선택 가이드

모든 비드 유형은 본래 동일한 어플리케이션 유형에 적용할 수 있습니다. 표적과 샘플, buffer, 적용한 솔루션의 특성에 따라 선택해야 합니다. 가능한 한 최상의 결과를 확보하려면, 어플리케이션에 가장 적합한 크기, 전하, 소수성 정도를 가진 비드를 선택합니다.

제품용량특징 및 특성이상적인 용도:
Dynabeads® M-280 Streptavidin유리 비오틴:
650–900 pmoles/mg 비드

비오틴화된 Ig:
5–10µg/mg 비드
  • 소수성 비드 표면
  • tosylactivated 비드 기반
    직경: 2.8µm
  • 크기 분포: CV 3% 미만
  • 차단 단백질 BSA
    등전점: pH 5.0
  • 저전하(–10mV(pH 7에서)
  • 철 함량(페라이트): 12%(17%)
  • 면역분석/면역진단
  • DNA/RNA 결합 단백질 정제
  • 단백질 정제
  • Phage 표시
  • 바이오패닝(Biopanning)
  • 세포 분리
    Dynabeads® MyOne™ Streptavidin T1유리 비오틴:
    1,300 pmoles/mg 이상의 비드

    비오틴화된 Ig:
    20µg/mg 비드
    • 소수성 비드 표면
    • tosylactivated 비드 기반
      직경: 1.05µm
    • 크기 분포: CV 3% 미만
      차단 단백질 BSA
    • 등전점: pH 5.0
    • 저전하(–10mV(pH 7에서)
    • 철 함량(페라이트): 26%(37%)
    • M-280/M-270 비드에 비해 느린 침강 속도와 개선된 반응 속도
    • 면역분석/면역진단
    • DNA/RNA 결합 단백질 정제
    • 단백질 정제
    • Phage 표시
    • 바이오패닝(Biopanning)
    • 세포 분리
    • 자동 어플리케션에 매우 적합
    Dynabeads® 
    M-270 Streptavidin
     
    유리 비오틴:
    650-1,350pmoles/mg 비드

    비오틴화된 Ig:
    5–10µg/mg 비드
    • 친수성 비드 표면
    • 카르복실산 비드 기반
    • 직경: 2.8µm
    • 크기 분포: CV 3% 미만
    • 차단 단백질 사용 안 함
    • 등전점: pH 4.5
    • 고전하(–50mV(pH 7에서)
    • 철 함량(페라이트): 14%(20%)
    • 고염 용액에서 낮은 비드 응집
    • 핵산 진단에서 염기서열 특이적 DNA/RNA 포획
    • GTC 용해 또는 높은 염 농도가 필요한 프로토콜에서 사용.
    • 단일 가닥 DNA 준비
    • 소수성 표적을 사용하는 면역분석/면역진단
    Dynabeads® MyOne™ Streptavidin C1유리 비오틴:
    2,500 pmoles/mg 이상의 비드

    비오틴화된 Ig:
    15-20µg/mg 비드
    • 친수성 비드 표면
    • 카르복실산 비드 기반
      직경: 1.05µm
    • 크기 분포: CV 3% 미만
    • 차단 단백질 사용 안 함
    • Tween 20 buffer
    • 등전점: pH 5.2
    • 보통의 전하(–35mV(pH 7에서))
      철 함량(페라이트): 26%(37%)
    • M-280/M-270 비드에 비해 느린 침강 속도와 개선된 반응 속도
    • 낮은 응집
    • 핵산 진단에서 염기서열 특이적 DNA/RNA 포획
    • 단일 가닥 DNA 준비
    • 고효율 핵산 정제 프로토콜
    • 질량분광분석법에 적합한 단백질 샘플 준비
    • 자동 어플리케션에 매우 적합
    Dynabeads® kilobaseBINDER™ Kitmg 비드당 70pmole의 4kb 비오틴화된 DNA 분절과 80 pmole의 10 kb 분절
    • Dynabeads® M-280 Streptavidin, 고유한 Binding Solution, Washing Solution 함유
    • 긴 비오틴화된 DNA 분절(2kb 이상) 고정
    • 세포질에서 빠르고, 효율적이고, 쉽게 핵 정제
    • 몇 분 내에 크로마틴 분리
    Dynabeads® Biotin Binder2 x 109 개 세포(PBMC) 또는 200mL의 전혈
    • 자체 표준 비오틴화 항체 사용
    • 전혈, 버피코트, PBMC, MNC, 절단 조직에서 세포 분리
    • 모든 종(species)의 모든 샘플에서 단일/여러 세포 유형 결핍
    • 분자 다음 단계 어플리케이션에서 양성 세포 분리(세포 방출 없음)
    CELLection® Biotin Binder Kit 2 x 109 개 세포(PBMC) 또는 200mL의 전혈
    • 자체 표준 비오틴화 항체 사용
    • 비드 표면의 Streptavidin은 DNA linker를 통해 부착되어 절단 가능 부위를 준비하여 분리 후 비드를 방출하고 제거
    • 양성 세포 분리 및 방출
    • 모든 종(species)의 모든 샘플에서 모든 세포 분리
    Dynabeads® FlowComp™ Flexi2 x 109 개 세포(MNC) 또는 80mL 전혈/버피코트 처리
    • 자체 항체 사용
    • 항체의 DSB-X 비오틴화는 비드에서 표적 세포 방출을 보장하는 데 필요함. 필요한 모든 성분이 키트에 들어 있음
    • 양성 세포 분리 및 방출
    • 모든 종(species)의 모든 샘플에서 모든 세포 분리